1.1 Ã§ÂÂÃ§ÂÂÃ§ÂÂÃ§ÂÂAbout GSK
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated 7% of the world's pharmaceutical market's also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.
Based on 2004 Annual Results, GSK had sales of Ã¯Â¿Â½.3 billion ($37.2 billion) and profit before tax of Ã¯Â¿Â½1 billion ($11.1 billion). Total pharmaceutical turnover was just over Ã¯Â¿Â½ billion ($31 billion) and consumer healthcare turnover was Ã¯Â¿Â½2 billion ($5.8 billion). GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D.GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about Ã¯Â¿Â½8bn/$5bn.
GlaxoSmithKline's business goal is to become the indisputable leader in the pharmaceutical and consumer healthcare industry. Achieving this goal will require meeting the three key challenges that face both the industry and society as a whole:...